Cas:72700-41-5 6,8-dichloro-4-piperazin-1-ylquinazoline manufacturer & supplier

We serve Chemical Name:6,8-dichloro-4-piperazin-1-ylquinazoline CAS:72700-41-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

6,8-dichloro-4-piperazin-1-ylquinazoline

Chemical Name:6,8-dichloro-4-piperazin-1-ylquinazoline
CAS.NO:72700-41-5
Synonyms:Quinazoline,6,8-dichloro-4-(1-piperazinyl);6,8-DICHLORO-4-PIPERAZIN-1-YL-QUINAZOLINE
Molecular Formula:C12H12Cl2N4
Molecular Weight:283.15600
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:41.05000
Exact Mass:282.04400
LogP:2.74000

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Quinazoline,6,8-dichloro-4-(1-piperazinyl) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6,8-DICHLORO-4-PIPERAZIN-1-YL-QUINAZOLINE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6,8-DICHLORO-4-PIPERAZIN-1-YL-QUINAZOLINE Use and application,Quinazoline,6,8-dichloro-4-(1-piperazinyl) technical grade,usp/ep/jp grade.


Related News: Now, with the support that continues to pour in, GEM is thrilled to launch our phase 3 program for long term housing with funding partners The Schul of Bal Harbour, EZS Events, Hatzalah of South Florida, and Ygrene. Sitagliptin N-Phoshate IMpurity manufacturers McNamara joined GSK from Novartis in 2015 when the two companies combined their OTC portfolios into a joint venture managed by GSK. He became head of GSK consumer health in 2016, taking the baton from Walmsley as she moved up the command chain to CEO of the entire group. Novartis in 2018 backed out of the collab, and after taking full control of the venture, GSK formed a new JV with Pfizer in 2019. (2,2-2H2)Butanoic acid suppliers India and China are two of the leading players in that game, and US legislators for months have pushed for an aggressive “onshoring” of drug production to counteract the nation’s reliance on foreign producers. Israel, a key ally to the US, could be a logical partner in that effort, but the Trump administration also took out big bets on US firms to set up shop stateside. 2-[(4-methylbenzoyl)amino]ethyl 4-methylbenzoate vendor & factory.